[Ru(CH=CHC6H4Me-4)Cl(2,1,3-benzothiadiazole)(bis(diphenylphosphino)methane)(CO)(PPh3)2] | 213336-45-9

• 英文名称: [Ru(CH=CHC6H4Me-4)Cl(2,1,3-benzothiadiazole)(bis(diphenylphosphino)methane)(CO)(PPh3)2]
• 英文别名: [Ru(CH=CH(C6H4Me-4))Cl(CO)(2,1,3-benzothiadiazole)(PPh3)2]
• CAS: 213336-45-9
• 化学式: C₅₂H₄₃ClN₂OP₂RuS
• 分子量: 942.463
• InChiKey: BHXXLORCOCNMSN-UHFFFAOYSA-M

计算性质

• 辛醇/水分配系数(LogP)：
  None
• 重原子数：
  None
• 可旋转键数：
  None
• 环数：
  None
• sp3杂化的碳原子比例：
  None
• 拓扑面积：
  None
• 氢给体数：
  None
• 氢受体数：
  None

反应信息

• 作为反应物：
  描述：

  4-羟甲基苯甲酸 、 [Ru(CH=CHC6H4Me-4)Cl(2,1,3-benzothiadiazole)(bis(diphenylphosphino)methane)(CO)(PPh3)2] 在 NaOCH₃ 作用下， 以 二氯甲烷 为溶剂， 以92%的产率得到Ru(CH=CHC6H4Me-4)(CO2C6H4CH2OH-4)(CO)(PPh3)2
  参考文献：
  名称：

  基于羧酸盐和黄药的配体的双金属配合物：合成和电化学研究。

  摘要：

  同双金属钌（II）和（II）络合物[{RuR（CO）（PPh（3））（2）}（2）（S（2）COCH（2）C（6）H（4）CH（ 2）OCS（2））]（R = CH = CHBu（t），CH = CHC（6）H（4）Me-4，C（C [三键] CPh）= CHPh，CH = CHCPh（2） OH）和[{Os（CH = CHC（6）H（4）Me-4）（CO）（PPh（3））（2）}（2）（S（2）COCH（2）C（6） H（4）CH（2）OCS（2））]易于从[MRCl（CO）（BTD）（PPh（3））（2）]的反应中形成（M = Ru或Os; BTD = 2,1 ，3-苯并噻二唑）与双黄药KS（2）COCH（2）C（6）H（4）CH（2）OCS（2）K。KS（2）COCH（2）C（6）H（4）CH（2）OCS（2）K加至两个当量的顺式[RuCl（2）（dppm）（2）]导致形成[{（dp

  DOI：

  10.1039/b901822k

文献信息

• Dithiocarboxylate complexes of ruthenium(ii) and osmium(ii)
  作者：Saira Naeem、Amber L. Thompson、Andrew J. P. White、Lionel Delaude、James D. E. T. Wilton-Ely

  DOI：10.1039/c1dt10048c

  日期：——

  The ruthenium(II) complexes [Ru(R)(κ2-S2C·IPr)(CO)(PPh3)2]+ (R = CHCHBut, CHCHC6H4Me-4, C(CCPh)CHPh) are formed on reaction of IPr·CS2 with [Ru(R)Cl(CO)(BTD)(PPh3)2] (BTD = 2,1,3-benzothiadiazole) or [Ru(C(CCPh)CHPh)Cl(CO)(PPh3)2] in the presence of ammonium hexafluorophosphate. Similarly, the complexes [Ru(CHCHC6H4Me-4)(κ2-S2C·ICy)(CO)(PPh3)2]+ and [Ru(C(CCPh)CHPh)(κ2-S2C·ICy)(CO)(PPh3)2]+ are formed

  这 钌（II）配合物的[Ru（R）（κ 2 -S 2 C·IPR）（CO）（PPH 3）2 ] +（R = CH CHBu吨，CH CHC 6 H ^ 4 ME-4，C（C CPH）CHPh配合）是由IPr·CS 2与[Ru（R）Cl（CO）（BTD）（PPh 3）2 ] （电信发展局 = 2,1,3-苯并噻二唑）或[Ru（C（C CPh）CHPh）Cl（CO）（PPh 3）2 ]六氟磷酸铵。类似地，复合物的[Ru（CH CHC 6 H ^ 4 ME-4）（κ 2 -S 2 C·的ICy）（CO）（PPH 3）2 ] +及[茹（C（C CPH）CHPh配合）（κ 2当使用ICy·CS 2时，以相同的方式形成-S 2 C·ICy）（CO）（PPh 3）2 ] +。配体IMES·CS 2与[Ru（R）Cl（CO）（BTD）（PPh 3）2]，以形成所述化合物的[Ru（R）（κ 2 -S 2 C·IMES）（CO）（PPH
• Multimetallic Complexes and Functionalized Nanoparticles Based on Unsymmetrical Dithiocarbamate Ligands with Allyl and Propargyl Functionality
  作者：Venesia L. Hurtubise、James M. McArdle、Saira Naeem、Anita Toscani、Andrew J. P. White、Nicholas J. Long、James D. E. T. Wilton-Ely

  DOI：10.1021/ic502015c

  日期：2014.11.3

  of group 8, 10, and 11 metals, [RuS2CN(CH2CH═CH2)Me}(dppm)2]+, [Ru(CH═CHC6H4Me-4)S2CN(CH2CH═CH2)Me}(CO)(PPh3)2], [NiS2CN(CH2CH═CH2)Me}(dppp)]+, and [AuS2CN(CH2CH═CH2)Me}(PPh3)] were formed successfully. Using KS2CN(CH2C≡CH)Me, the complex [RuS2CN(CH2C≡CH)Me}(dppm)2]+ was obtained from cis-[RuCl2(dppm)2]. One palladium example, [PdS2CN(CH2C≡CH)Me}(PPh3)2]+, was also isolated in low yield. However

  新的，二硫代氨基甲酸不对称配体，KS 2 CN（CH 2 CH = CH 2）Me和KS 2 CN（CH 2 C≡CH）箱，从与KOH和二硫化碳反应相应胺形成。均配型配合物[镍S 2 CN（CH 2 CH = CH 2）Me} 2 ]和[M S 2 CN（CH 2 C≡CH）Me} 2 ]（M =镍，钯，铂）形成与合适的金属前体反应。两个侧基官能之间的转换是通过氢化证实[镍S 2 CN（CH 2 C≡CH）Me} 2 ]得到[倪S 2CN（CH 2 CH = CH 2）Me} 2 ]。组8，10的monodithiocarbamate化合物，和11族金属，的[Ru S 2 CN（CH 2 CH = CH 2）Me}（DPPM）2 ] +，[茹（CH = CHC 6 H ^ 4 ME-4）小号2 CN（CH 2 CH = CH 2）Me}（CO）（PPH 3）2 ]，[镍S 2
• Multifunctional Dithiocarbamates: Synthesis and Ring-Closing Metathesis of Diallyldithiocarbamate Complexes
  作者：Saira Naeem、Andrew J. P. White、Graeme Hogarth、James D. E. T. Wilton-Ely

  DOI：10.1021/om1002123

  日期：2010.6.14
• Ruthenium hydride and vinyl complexes supported by nitrogen–oxygen mixed-donor ligands
  作者：James D.E.T. Wilton-Ely、Ming Wang、Sanaz J. Honarkhah、Derek A. Tocher

  DOI：10.1016/j.ica.2005.04.036

  日期：2005.7

  The Schiff base, 2-chlorophenylsalicylaldimine (HL1), is formed readily from salicylaldehyde and 2-chloroaniline. After deprotonation, this ligand is found to react as a bidentate mixed-donor chelate with the complexes [RuRCl(CO)(BTD)(PPh3)(2)] (R = H, CH=CHC6H5, CH=CHC6H4Me-4, CH=CH'Bu, CC CPh=CHPh; BTD = 2,1,3-benzothiadiazole) to form the compounds [RuR(L-1)(CO)(PPh3)(2)] through displacement of the chloride and BTD ligands. An analogous reaction occurs with the osmium complex [OsHCl(CO)(BTD)(PPh3)(2)] to provide [OsH(L-1)(CO)(PPh3)(2)]. The compound [Ru(CH=CHC6H4Me-4)(L-1)(CO)(PPh3)(2)] is formed through reaction of salicylalclehyde (HL2) with [Ru(CH=CHC6H4Me-4)Cl(CO)(BTD)(PPh3)(2)] in the presence of base. Two further ligands were investigated to extend the study to encompass 5- and 4-membered chelates; 8-hydroxyquinoline (HL3) and 2-hydroxy-4-methylquinoline (HL4) react with [Ru(CH=CHPh)Cl(CO)(BTD)(PPh3)(2)] and [Ru(CH=CHC6H4Me-4)Cl(CO)(BTD)(PPh3)(2)] in the presence of base to yield the complexes [Ru(CH=CHPh)(L-3)(CO)(PPh3)(2)] and [Ru (CH=CHC6H4Me-4)(L-4)(CO)(PPh3)(2)], respectively. The crystal structure of [Ru(CH=CHC6H4Me-4)(L-1)(CO)(PPh3)(2)] is reported. (c) 2005 Elsevier B.V. All rights reserved.